Keele Research Repository

Article

Glynn, D, Bliss, J, Brunt, AM ORCID: https://orcid.org/0000-0002-4797-5097, Coles, CE, Wheatley, D, Haviland, JS, Kirby, AM, Longo, F, Faria, R, Yarnold, JR and Griffin, S (2022) Cost-effectiveness of 5 fraction and partial breast radiotherapy for early breast cancer in the UK: model-based multi-trial analysis. Breast Cancer Research and Treatment. 1 - 12.

Brunt, AM ORCID: https://orcid.org/0000-0002-4797-5097, Haviland, JS, Kirby, AM, Somaiah, N, Wheatley, DA, Bliss, JM and Yarnold, JR (2021) Five-fraction Radiotherapy for Breast Cancer: FAST-Forward to Implementation. Clinical Oncology.

Obeng-Gyasi, S, Coles, CE, Jones, J, Sacks, R, Lightowlers, S, Bliss, JM, Brunt, AM ORCID: https://orcid.org/0000-0002-4797-5097, Haviland, JS, Kirby, AM and Kalinsky, K (2021) When the World Throws You a Curve Ball: Lessons Learned in Breast Cancer Management. American Society of Clinical Oncology educational book, 41. 1 - 11.

Brunt, AM ORCID: https://orcid.org/0000-0002-4797-5097, Haviland, JS, Wheatley, DA, Sydenham, MA, Alhasso, A, Bloomfield, D, Chan, C, Churn, M, Cleator, S, Coles, CE, Emson, M, Goodman, A, Harnett, A, Hopwood, P, Kirby, AM, Kirwan, C, Morris, C, Nabi, Z, Sawyer, E, Somaiah, N, Stones, L, Syndikus, I, Wilcox, M, Bliss, JM and Yarnold, JR (2020) FAST-Forward phase 3 RCT of 1-week hypofractionated breast radiotherapy: 5-year results. Radiotherapy and Oncology, 152 (S1). S346 - S347.

Brunt, AM, Haviland, JS, Wheatley, DA, Sydenham, MA, Alhasso, A, Bloomfield, DJ, Chan, C, Churn, M, Cleator, S, Coles, CE, Goodman, A, Harnett, A, Hopwood, P, Kirby, AM, Kirwan, CC, Morris, C, Nabi, Z, Sawyer, E, Somaiah, N, Stones, L, Syndikus, I, Bliss, JM, Yarnold, JR and FAST-Forward Trial Management Group, . (2020) Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. The Lancet, 395 (10237). 1613 - 1626.

Coles, CE, Griffin, CL, Kirby, AM, Haviland, JS, Titley, JC, Benstead, K, Brunt, AM ORCID: https://orcid.org/0000-0002-4797-5097, Chan, C, Ciurlionis, L, Din, OS, Donovan, EM, Eaton, DJ, Harnett, AN, Hopwood, P, Jefford, ML, Jenkins, PJ, Lee, CE, McCormack, M, Sherwin, L, Syndikus, I, Tsang, Y, Twyman, NI, Ventikaraman, R, Wickers, S, Wilcox, MH, Bliss, JM and Yarnold, JR (2019) Dose escalated simultaneous integrated boost radiotherapy for women treated by breast conservation surgery for early breast cancer: 3-year adverse effects in the IMPORT HIGH trial (CRUK/06/003). Cancer Research, 79 (4).

Coles, CE, Griffin, CL, Kirby, AM, Titley, J, Agrawal, RK, Alhasso, A, Bhattacharya, IS, Brunt, AM ORCID: https://orcid.org/0000-0002-4797-5097, Ciurlionis, L, Chan, C, Donovan, EM, Emson, MA, Harnett, AN, Haviland, JS, Hopwood, P, Jefford, ML, Kaggwa, R, Sawyer, EJ, Syndikus, I, Tsang, YM, Wheatley, DA, Wilcox, M, Yarnold, JR, Bliss, JM and Trialists, IMPORT (2017) Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial. Lancet, 390 (10099). 1048 - 1060.

Conference or Workshop Item

Coles, C, Haviland, JS, Kirby, AM, Bhattacharya, I, Brunt, AM ORCID: https://orcid.org/0000-0002-4797-5097, Chan, C, Donovan, EM, Eaton, DJ, Griffin, CL, Hopwood, P, Jefford, ML, Lightowlers, S, Rajapakse, C, Sawyer, E, Stones, L, Syndikus, I, Titley, JC, Tsang, Y, Twyman, NI, Bliss, JM and Yarnold, JR (2021) IMPORT HIGH trial: Dose escalated simultaneous integrated boost radiotherapy in early breast cancer. In: ESTRO 2021, 28-31 August 2021, Madrid, Spain & Online.